Related references
Note: Only part of the references are listed.Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study
Sarah H. Wild et al.
ATHEROSCLEROSIS (2009)
Association of insulin resistance and inflammation with peripheral arterial disease - The National Health and Nutrition Examination Survey, 1999 to 2004
Reena L. Pande et al.
CIRCULATION (2008)
Symptomatic peripheral arterial disease in women - Nontraditional biomarkers of elevated risk
Aruna D. Pradhan et al.
CIRCULATION (2008)
Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Comparison of different definitions of pediatric metabolic syndrome: Relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers
Sojung Lee et al.
JOURNAL OF PEDIATRICS (2008)
Measures of obesity and cardiovascular risk among men and women
Rebecca P. Gelber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Metabolic syndrome and incident end-stage peripheral vascular disease
Jianjun Wang et al.
DIABETES CARE (2007)
Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study
David Conen et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment.: Atorvastatin on inflammatory markers study:: A substudy of achieve cholesterol targets fast with atorvastatin stratified titration
Luis Miguel Blanco-Colio et al.
AMERICAN HEART JOURNAL (2007)
Metabolic syndrome and risk of incident cardiovascular events and death - A systematic review and meta-analysis of longitudinal studies
Apoor S. Gami et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population
Y He et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age
C Lahoz et al.
DIABETES CARE (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease
JD Vu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study
JM Dekker et al.
CIRCULATION (2005)
Vitamin E in the primary prevention of cardiovascular disease and cancer - The Women's Health Study: A randomized controlled trial
IM Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
C-reactive protein modulates risk prediction based on the Framingham score -: Implications for future risk assessment:: Results from a large cohort study in southern Germany
W Koenig et al.
CIRCULATION (2004)
The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm
JK Olijhoek et al.
EUROPEAN HEART JOURNAL (2004)
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
S Malik et al.
CIRCULATION (2004)
Prevalence of and risk factors for peripheral arterial disease in the United States - Results from the National Health and Nutrition Examination Survey, 1999-2000
E Selvin et al.
CIRCULATION (2004)
C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study
MK Rutter et al.
CIRCULATION (2004)
Atherosclerotic vascular disease conference - Writing group III: Pathophysiology
DP Faxon et al.
CIRCULATION (2004)
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
N Sattar et al.
CIRCULATION (2003)
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events
PM Ridker et al.
CIRCULATION (2003)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Baseline characteristics of participants in the women's health study
KM Rexrode et al.
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2000)
Share Paper
